time
[용어속성] abnormalities
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol
Letter
[키워드] 1:1
24 hour
Administered
airway
allocation concealment
Alpha
ambient
analysed
aneurysms
Anticoagulant treatment
anticoagulation
antiplatelet
Arm
arterial
assigned
Atrial fibrillation
bleeding
bleeding event
block size
Blood
BMI
Body
Breastfeeding
breath
calculated
Cancer
clinical
clinically
Coagulopathy
Concomitant
conjunctival
Continuous
contributed
Control
control group
Controlled trial
corpus
COVID-19
COVID19
criteria
Critical
D-dimer
D-dimer level
Day
death
defined
detect
diagnostic
discharged
disease severity
dissemination
dosage
dose
effective
Efficacy and safety
element
enoxaparin
Epistaxis
EudraCT
event
events
expected
fibrinogen level
gingival bleeding
group
Haemoglobin
haemoptysis
health-care
hematemesis
hematoma
hemodynamic
heparin
High dose
high risk
history
hospital discharge
Hospital stay
hospitalized patient
hypersensitivity
Hypothesis
IL-6
Impaired
impairing
improvement
IMV
In-hospital
indication
initiated
Inpatient
INR
internal
Intervention
intervention group
Intra-articular
intramuscular
invasive
Invasive mechanical ventilation
involved
Italian
Italy
laboratory parameter
LMWH
low dose
low-molecular weight heparin
macroscopic
Major
major bleeding
management
Mechanical
mechanical ventilation
medical intervention
Medicine
Modena
NIV
Non-invasive
number
objective
occur
Occurrence
open label
ophthalmic
oral anticoagulant
outcome
oxygen
paO2/fiO2
parallel group
participant
pathology
Patient
performed
Pharyngeal swab
plasma
Platelet
Pneumonia
positive
pregnancy test
Presence
pressure
Primary outcome
prophylactic dose
prosthetic
protocol
random
randomisation
randomised
randomised controlled
randomised controlled trial
randomization
Rate
receiving
recorded
recruited
Rectal Bleeding
reduce
reduction in
Registered
renal function
reported
required
respiratory
risk
risk of death
Sample size
SARS-CoV-2
secondary
secure
Severe COVID-19 pneumonia
severe disease
significantly
Spontaneous
standard oxygen therapy
Stata
status
stratified
stroke
study drug
Study protocol
subcutaneously
surgical
susceptible
symptomatic
syndrome
therapeutic dose
therapy
thrombocytopenia
time
transfusion
Treatment
unfractionated heparin
unit
Vascular
venipuncture
Venous Thromboembolism
web-based system
website
weight
Withdrawal
worsening
[DOI] 10.1186/s13063-020-04475-z PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04475-z PMC 바로가기 [Article Type] Letter
Multiple Ensemble Neural Network Models with Fuzzy Response Aggregation for Predicting COVID-19 Time Series: The Case of Mexico
Article
[키워드] aggregate
aggregation
approach
Complete
composed
conditions
country
COVID-19
COVID-19 time series
ensembles
Final
Fuzzy logic
Model
Multiple
network
Neural
neural networks
predicted
response
significantly lower
time
was tested
[DOI] 10.3390/healthcare8020181 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/healthcare8020181 PMC 바로가기 [Article Type] Article
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis
Research Article
[키워드] activated
addition
aPTT
AUC
change
coagulation indicator
correlated
correlation
COVID-19
COVID-19 infection
critically ill patients
D-dimer
Deceased
disorder
dysfunction
early stage
fibrinogen
Indicator
lab
Mortality
mortality risk
objective
occur
occurred
Patient
Poor
Prognosis
progression
prothrombin
Prothrombin time
Result
ROC analysis
Science
severity and prognosis
Significant
technology
tested
the disease
thrombin
time
university
Wuhan
[DOI] 10.1155/2020/6159720 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2020/6159720 PMC 바로가기 [Article Type] Research Article
D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis
Research Article
[키워드] activated
addition
aPTT
AUC
change
coagulation indicator
correlated
correlation
COVID-19
COVID-19 infection
critically ill patients
D-dimer
Deceased
disorder
dysfunction
early stage
fibrinogen
Indicator
lab
Mortality
mortality risk
objective
occur
occurred
Patient
Poor
Prognosis
progression
prothrombin
Prothrombin time
Result
ROC analysis
Science
severity and prognosis
Significant
technology
tested
the disease
thrombin
time
university
Wuhan
[DOI] 10.1155/2020/6159720 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2020/6159720 PMC 바로가기 [Article Type] Research Article
Reorganization Tips from a Sarcoma Unit at Time of the COVID-19 Pandemic in Italy: Early Experience from a Regional Referral Oncologic Center
Article
[키워드] applied
Cancer center
Cancer patients
center
COVID-19
crisis
Elective
equipment
experience
Follow-up
Health
health emergency
Healthcare system
hospital
indication
lockdown
maintain
management
Novel coronavirus
oncology
operative
orthopedic
outbreak
outpatient clinic
pathologic
Patient
Protective
Referral
Regional
reorganization
risk
Safe
Sarcoma
Screening
social distancing
Swab
time
tissue
treatment protocols
Tumor
unit
World Health Organization
[DOI] 10.3390/jcm9061868 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/jcm9061868 PMC 바로가기 [Article Type] Article
Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)
중증 COVID-19 환자를 치료하기 위한 동종 인간 치수 줄기세포의 안전성 및 효능 평가: 무작위 대조 시험(I/II상)을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
Acidic
Adenovirus
Admission
AIDS
Alanine
alanine aminotransferase
albumin
alkaline phosphatase
Allogeneic
allogeneic human dental pulp stem cells
amyloid
Analysis
anion gap
Arm ratio
aspartate
Aspartate aminotransferase
average
B lymphocyte
basophils
Before menopause
Bilirubin
blind
blinded
Block randomization method
Blood
blood cell
Blood cells
blood pressure
Blood routine
C-reactive protein
calcium
carbon dioxide
Care
CAST
caused
Cell
cell suspension
change
chest X-ray
Child Pugh score
chlorine
cholesterol
cholinesterase
CLARITY
clinical
Clinical improvement
clinical trial
coded
Coefficient of variation
color
commenced
comparator
computer
Concentration
Consent
consent form
Continuous renal replacement therapy
control group
control groups
COVID-19
COVID-19; randomised controlled trial; protocol; human dental pulp stem cells; dental stem cell banking
COVID-2019
creatine
creatine kinase
creatinine
criteria
crystal
Cytokines
cytomegalovirus
cytomegalovirus CMV-IgG
cytomegalovirus CMV-IgM
Definition
dental pulp
dental pulp stem cells
description
detect
Diastolic blood pressure
direct bilirubin
discharge
disease
dissemination
distress
distribution
DPSCs
ECMO
Efficacy
element
enrolled
eosinophil
eosinophils
epithelial cells
estimated glomerular filtration rate
Estrogen
examined
excluded
exclusion criteria
experimental group
fat globules
Female patients
female subject
filtration rate
Final
flow cytometry
follow-up period
fungi
fungus
Globulin
glomerular filtration rate
Glucose
GRADE
Grade 1
grade 3
Grade 5
granulocyte
HBcAb
HBeAb
HBeAg
HBsAb
HBsAg
hDPSCs
Health Organization
heart rate
hematocrit
Hemodialysis
hemoglobin
hepatitis B
hepatitis C
HFNC
high density lipoprotein
hospitalised patient
Hospitalised patients
Hospitalization
Hospitalized
human DPSC
human DPSCs
hypersensitive C-reactive protein
hypoxia
Identifier
IgA
IgG
IgM
Il -10
IL-1
IL-1 β
IL-2
IL-4
IL-6
immune
Immunoglobulin
Immunological testing
improvement
IMV
inclusion criteria
Infectious disease
Influenza
Influenza virus
informed consent form
injection
Injections
intensive care
intensive care unit
Intravenous injection
Invasive mechanical ventilation
investigator
investigators
ITN-γ
ketone
ketone bodies
Kidney function
Kidney function tests
Killer cell
Laboratory
laboratory examinations
Lactate
lactate dehydrogenase
lactating women
leukocyte
leukocyte enzymes
lipoprotein
lipoprotein A
lipoprotein cholesterol
low density lipoprotein
lung lesion
lung lesions
lymphocyte
Lymphocytes
Macrophage
Magnesium
Medical care
Menopause
Monocytes
mononuclear cell
mononuclear cells
nasal
nasal catheter
natural killer
natural killer cell
neutrophil
Neutrophils
nitrite
NIV
Non-invasive
non-invasive mechanical ventilation
non-squamous epithelial cell
non-squamous epithelial cells
nucleic acid
nucleic acid test
number
objective
observation
occult
occult blood
Other
Other condition
outcome
oxygen
oxygen saturation
parallel group
parasites
partial pressure
participant
Patient
penetration
performed
Peripheral blood
Peritoneal dialysis
phase
phenotype
phosphatase
phosphorus
Placebo
placebo-controlled
Platelet
Platelet count
platelet distribution width
Platelets
Potassium
prealbumin
pregnancy test
pregnant
pressure
Primary outcome
Protein
protocol
random
randomisation
randomization
Randomized
Randomized controlled trial
receive
receiving
recruitment
red blood cell
red blood cells
renal
renal insufficiency
renal replacement therapy
Renmin Hospital
replacement therapy
required
researcher
respiratory
respiratory distress
respiratory infection
respiratory rate
Safety
Saline
saline solution
Sample size
SARS-CoV-2
secondary
Secondary outcomes
serious COVID-19
serum
serum amyloid
severe liver condition
severe pneumonia
single-cell analyses
sodium
specific gravity
Standard deviation
status
stem cell
study period
Study protocol
sugar
syphilis
Systolic blood pressure
T lymphocyte
Th1 cytokine
Th1 cytokines
Th2 cytokine
Th2 cytokines
therapeutic effect
therapeutic effects
time
TNF-a
Total
total bilirubin
Total cholesterol
total protein
traits
Transferrin
treat
Treatment
treatment for COVID-19
triacylglycerol
Trial
triple blinded
TTCI
Tuberculosis
Twenty participant
Twenty participants
university
urea
uric acid
Urine
urobilinogen
Variation
Version
vital signs
Volume
website
White blood cells
with HIV
within 6 months
women
World Health Organization
Wuhan
γ-glutamyl transferase
[DOI] 10.1186/s13063-020-04380-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04380-5 PMC 바로가기 [Article Type] Letter
Influence of the SARS-CoV-2 Outbreak on the Uptake of a Popular Smoking Cessation App in UK Smokers: Interrupted Time Series Analysis
Original Paper
[키워드] acute respiratory syndrome
adjusted
analyses
Analysis
app
approach
association
Bayes factor
calculation
collected
coronavirus
covariate
COVID-19
downloaded
Evidence
examined
finding
Free
Generalized
greater
Inconclusive
indicated
influence
Interrupted
Mobile health
null hypothesis
objective
outbreak
outcome
primary analysis
public health
Result
SARS-CoV-2
Sery
smartphone app
smoke
smoker
smoking
smoking cessation
Support
the SARS-CoV-2
time
Time series analysis
United Kingdom
uptake
[DOI] 10.2196/19494 PMC 바로가기 [Article Type] Original Paper
[DOI] 10.2196/19494 PMC 바로가기 [Article Type] Original Paper
Adding Colchicine to the Antiretroviral Medication – Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial
Letter
[키워드] 1:1
added
Adding
anti-inflammatory effect
Antibiotics
anticipated
antioxidant
antioxidants
antiretroviral
blinded
both group
CDC
center
change
Clinical course
Clinical improvement
Colchicine
component
Consensus
Controlled
COVID-19
COVID-19 infection
COVID-19 patients
digoxin
dissemination
dosage
double blind
double-blind study
element
enrolled
equation
estimate
Final
GFR
glomerular filtration rate
group
help
Hospital stay
hospitalized COVID-19 patients
hypersensitivity
hypoxic
in both group
infected with COVID-19
Inflammation
inflammatory disorders
Inpatient
interleukin-8
intubation
invasive
Iran
Kaletra
kidney transplant recipients
Lopinavir/ritonavir
lung
Lung CT
MDA
mechanism
Minerals
Nasopharyngeal swab
National
number
objective
outcome
oxidative stress
Oxygenation
pandemic
parallel group
participant
pathologic
pathway
Patient
patients
percentage
Pneumonia
positive
Prospective
protocol
QTc
randomised
randomised controlled trial
randomization
Randomized
Rate
Ratio
receive
recruited
recruitment
reducing
reduction
Registered
RT -PCR
Sample size
serum creatinine
status
Tehran
time
tomography
Trace element
treat
treated
Treatment
two group
two groups
Vitamin
website
WHO guideline
with COVID-19
[DOI] 10.1186/s13063-020-04455-3 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04455-3 PMC 바로가기 [Article Type] Letter
COVID-19: Time for Post-Exposure Prophylaxis?
Review
[키워드] acute respiratory syndrome
addressed
antiviral drugs
Contact
contagious
contagiousness
coronavirus
coronavirus disease
COVID-19
COVID-19 pandemic
General population
healthcare
healthcare worker
help
individual level
Infection
Influenza
Intervention
Lopinavir-ritonavir
MERS
Middle East
mitigate
novel coronavirus SARS-CoV-2
Occurrence
other respiratory virus
Perspective
post-exposure
Prevent
Prophylaxis
quarantine
ribavirin
SARS-CoV-2
South Korea
Spread
subject
syndrome
time
use of hydroxychloroquine
virus
[DOI] 10.3390/ijerph17113997 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/ijerph17113997 PMC 바로가기 [Article Type] Review